Merck & Company, Inc.
Long
Updated

MRK Breakout from Lows

65
Reports Earnings Feb 2nd, Biotech yet to breakout, may have bottomed here
Note
1Q 2018 PDUFA Lynparza
1Q 2018 Phase 3 data MK-3475-189/KEYNOTE-189

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.